Prochlorperazine Maleate Buccal Tablets Suppliers & Bulk Manufacturers

Available Forms: Buccal tablets

Available Strengths: 3 mg

Reference Brands: US: Compazine®, Procomp®; EU: Stemetil®, Buccastem®

Category: Antipsychotropic Drugs

Prochlorperazine maleate buccal tablets block dopamine D2 receptors in the chemoreceptor trigger zone, helping reduce nausea and vomiting. Placed between the gum and cheek, they allow sustained absorption. Commonly used for vertigo, migraine-associated nausea, and chemotherapy-induced emesis when non-invasive, long-lasting relief is preferred. Prochlorperazine Maleate Buccal tablets is available in Buccal tablets and strengths such as 3 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Prochlorperazine Maleate Buccal tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Prochlorperazine Maleate Buccal tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Prochlorperazine maleate buccal tablets are approved in the USA by the FDA for the management of severe nausea and vomiting, including those associated with migraines and chemotherapy. The buccal route provides prolonged therapeutic levels with convenient, non-invasive administration. In the EU, these tablets are regulated under centralized or national procedures, depending on the member state, and require GMP-compliant manufacturing and detailed pharmacovigilance data. The formulation offers an alternative for patients who cannot tolerate oral or injectable forms. Explore other forms of Prochlorperazine at Pharmatradz.com.